EPO and glaucoma: Another group utilized a recombinant adeno-associated virus (rAAV) encoding EPO.R76E, a form of EPO with attenuated erythropoietic activity that has been shown to preserve RGC axons, cell bodies, and vision in the DBA/2J model of glaucoma [18,50].